| Outcome Measures: |
Primary: Change in lean tissue mass, Measured by body composition monitor (BCM), 16 weeks | Secondary: Skeletal muscle quality index (SMQI), Assessed by muscle ultrasound, 16 weeks|Change in adipose tissue mass from baseline, 16 weeks|Change in hand grip strength from baseline, Measured by hand dynamometer, expressed as percentile of reference (by age and gender), 16 weeks|Change in kidney disease quality of life (KDQoL-36) energy/fatigue scale from baseline, Assessed by Kidney Disease Quality of Life-36 (KDQoL-36) survey (energy/fatigue scale, 0-100, higher is better), 16 weeks|Change in kidney disease quality of life (KDQoL-36, overall health rating) from baseline, Assessed by Kidney Disease Quality of Life-36 (KDQoL-36) survey (0-100, higher is better), 16 weeks|Positive and negative affect, Assessed by Positive and Negative Affect Schedule (PANAS, 0-100, higher is better), 16 weeks|Change in phase angle from baseline, Assessed by Body Composition Monitor (BCM), 16 weeks|Change in body weight from baseline, 16 weeks|Change in serum prealbumin concentration from baseline, 16 weeks | Other: Subjective global assessment (SGA), 7-point scale, 7 indicates normal nutritional status, 1 indicates severe protein energy wasting, 16 weeks|Change in serum albumin concentration, 16 weeks|Appetite, Numeric rating scale (0-10, 10 being best appetite), 16 weeks
|
